Download Constitutive BR3 receptor signaling in diffuse, large

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Constitutive BR3 receptor signaling in diffuse, large B-cell
lymphomas stabilizes nuclear factor-κB–inducing kinase
while activating both canonical and alternative nuclear
factor-κB pathways
by Lan V. Pham, Lingchen Fu, Archito T. Tamayo, Carlos Bueso-Ramos, Elias
Drakos, Francisco Vega, L. Jeffrey Medeiros, and Richard J. Ford
Blood
Volume 117(1):200-210
January 6, 2011
©2011 by American Society of Hematology
Identification and characterization of NF-κB family members in DLBCL subsets.
Lan V. Pham et al. Blood 2011;117:200-210
©2011 by American Society of Hematology
Immunohistochemical analysis of NF-κB components in DLBCL cell lines and primary DLBCL
samples.
Lan V. Pham et al. Blood 2011;117:200-210
©2011 by American Society of Hematology
NF-kB DNA-binding analysis in DLBCL cell lines and primary samples.
Lan V. Pham et al. Blood 2011;117:200-210
©2011 by American Society of Hematology
NIK kinase protein accumulates in DLBCL tumor cells.
Lan V. Pham et al. Blood 2011;117:200-210
©2011 by American Society of Hematology
BR3 receptor activation promotes DLBCL cell growth through NIK protein stabilization.
Lan V. Pham et al. Blood 2011;117:200-210
©2011 by American Society of Hematology
The role of TRAF3 in the stabilization of NIK in DLBCL cells.
Lan V. Pham et al. Blood 2011;117:200-210
©2011 by American Society of Hematology
Constitutive BLyS/BR3 signaling activates NIK-induced NF-κB pathway activation through
induction of TRAF3 degradation in DLBCL. (A) Cytoplasmic cell lysates from MS-GCB or HBABC DLBCL cells were immunoprecipitated with BR3 or TRAF3 antibodies and probed wi...
Lan V. Pham et al. Blood 2011;117:200-210
©2011 by American Society of Hematology
Related documents